But first what is EllieMD
The results of a trial of semaglutide in obese patients with HFpEF showed a significant amelioration of symptoms and improvements in motor function and weight loss compared with patients treated with a placebo.470 In this study, researchers randomized 529 patients with heart failure with a preserved ejection fraction and body mass index (weight in kilograms in the square of the height in meters) 30 to receive once-weekly injections of semaglutide (2.4 mg) or placebo for 52 weeks
If youve tried diet and exercise but still struggle with weight management, GLP-1 medications might be worth discussing with your doctor
Ongoing Monitoring and Check-ins Regular appointments track your progress, catch any developing side effects early, and adjust your plan as your body changes
Can you send me the coverage policy in writing?" WHAT TO EXPECT BY PLAN TYPE Anthem's 2025 Zepbound Coverage Here's the realistic coverage landscape for Anthem members in 2025: Coverage by Plan Type and Region 2025 GLP-1 Coverage Rollbacks Major Coverage Changes in 2025-2026 Several Blue Cross/Blue Shield plans (including Anthem affiliates) are tightening or eliminating GLP-1 weight loss coverage due to cost concerns: California Medi-Cal (Anthem): Ended all GLP-1 weight loss coverage on 1/1/2026
Nadolsky has observed that while some individuals may require the highest dose of GLP-1 agonists for the rest of their lives, others can gradually reduce their medication